Biden Administration's Threat to Use 'March-In Rights' on Prescription Drugs

The Biden administration is threatening to use 'march-in rights' to increase government control over prescription drugs, which could impact innovation in the pharmaceutical industry. Critics argue that this move is more about expanding government power than helping consumers with affordable medical expenses.